Healthcare Industry News: ENTityXL
News Release - September 7, 2018
Optim Partners with 21st Century Oncology as the Preferred Vendor for Head and Neck Cancer EndoscopyThe ENTity™ XL Nasopharyngoscope has been selected by the leading health care provider as the preferred choice in technology utilized to diagnose and manage patients with head and neck cancers.
STURBRIDGE, Mass., Sept. 7, 2018 -- (Healthcare Sales & Marketing Network) -- Optim LLC, a premier manufacturer of proprietary flexible endoscopes for use in the visual diagnosis of Ear-Nose-and-Throat ("ENT") disorders, announced today it has been chosen by 21st Century Oncology as the Preferred Vendor for new and replacement equipment used to diagnose and manage head and neck cancer disorders. 21st Century is Headquartered in Fort Myers, Florida, the physician-led company operates 167 treatment centers, including 131 centers located in 16 U.S. states. The Company also operates 36 centers located in seven countries in Latin America.
"We're happy to have been selected by 21st Century as a partner in their focus on delivering innovative and comprehensive patient care," stated Doug Hughes, President and CEO of Optim. "Our patented ENTityXL enables clinicians to treat patients with an easy-to-use, high quality imaging system backed by first-rate customer support."
The ENTityXL is designed as an optimal system allowing clinicians to meet the growing need for effective treatment and management of head and neck cancers in their patient population. The mobility of the XL enables procedures in hospital, office, ambulatory surgery center, or long-term care settings. The patented internal lighting system provides true portability of the ENTity XL system allowing the physician to take the technology to the patient, rather than the patient to the technology.
Optim LLC designs, develops, manufactures and markets state-of-the-art imaging products and accessories that help professionals in the medical, law enforcement, and industrial markets perform visualization procedures more effectively and efficiently. The ENTity Series for medical and the FreedomView Series for industrial and security markets utilize the company's patented OptiLux™ LED lighting technology freeing users from tethered or bulky external devices. Optim owns the trademarks for Optim, ENTity, FreedomView, and OptiLux. Information about Optim's products is available at www.optim-llc.com.
About 21st Century
21st Century Oncology is the premier provider of cancer care services across multiple modalities, the largest radiation oncology provider and one of the largest groups of urologists in the U.S. For more than 30 years, 21st Century Oncology has been committed to providing state-of-the-art, academic quality radiation therapy and other cancer treatments in a patient-centric setting focused on continuous innovation.
Source: Optim LLC
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.